ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1427	National Cancer Institute	Html	en	Cancer Pain (PDQ®)–Patient Version	Expert-reviewed information summary about pain as a complication of cancer or its treatment. Approaches to the management and treatment of cancer-associated pain are discussed.	pain pathway 0.562753 cancer treatment 0.530419 opioid doses 0.512563 certain older patients 0.494486 blocks pain 0.560936 PDQ cancer information 0.578981 Skin pain 0.59257 pain medicine 0.620891 pain treatment 0.60597 different opioid 0.496343 pain control plan 0.622009 means mild pain 0.593227 cancer information summary 0.53585 bone pain 0.598741 PDQ Cancer Pain 0.631355 patients 0.72567 cancer patients 0.497501 Poor pain 0.553511 NCI PDQ cancer 0.498652 effects 0.513118 radiation therapy 0.594681 patients better pain 0.603263 chronic pain 0.55423 pain control medicine 0.611052 new pain 0.590569	breakthrough pain 0.577542 palliative care 0.539853 Pain relievers 0.575317 pain control 0.678976 Treating Cancer Pain 0.619773 National Cancer Institute 0.532557 commonly used opioid 0.491401 pain relief 0.639394 cancer pain 0.765349 older patients 0.709433 pain 0.970646 current pain treatments 0.604816 healthcare team 0.547409 drugs 0.511492 opioid treatment 0.49086 external radiation therapy 0.506549 intense pain 0.577346 severe pain 0.654451 PDQ summary 0.540695 control pain 0.601004 pain levels 0.579761 means moderate pain 0.593293 pain threshold 0.556519 means severe pain 0.59891	CLICK HERE
1473	National Cancer Institute	Html	en	Gallbladder Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of gallbladder cancer.	similar median OS 0.628591 intact organ function 0.622839 PDQ cancer information 0.730699 extrahepatic bile duct 0.642047 standard surgical procedure 0.635592 Systemic chemotherapy 0.571595 lymphatic tissue 0.570673 biliary obstruction 0.585733 cancer information summary 0.709899 breast cancer prevention 0.628762 hematologic toxic effects 0.620759 delayed recurrences 0.576123 gallbladder cancer. 0.68322 median overall survival 0.632156 surgical specimen 0.573532 wedge resection 0.601072 liver tissue 0.572719 port sites 0.635991 single institution 0.570884 metastatic gallbladder cancer 0.742217 NCI’s PDQ 0.589794 NCI PDQ cancer 0.658789 lymph nodes 0.686365 consecutive surgical patients 0.660543	laparoscopic removal 0.566309 N2 lymph node 0.694743 gallbladder cancer 0.941749 transhepatic biliary drainage 0.640041 node positive tumors 0.650245 single-agent gemcitabine 0.568199 hepatoduodenal ligament 0.573622 surgical intervention. 0.574213 muscle layer 0.568687 routine gallbladder operation 0.744072 unsuspected cancer 0.606476 phase III study 0.612031 5-year survival 0.582018 advanced biliary cancers 0.636965 PDQ documents 0.58963 platinum agents 0.566154 gallbladder bed 0.684231 transient partial remissions 0.621529 node negative tumors 0.647847 adequate performance status 0.625607 unsuspected gallbladder cancer 0.785275 Long-term disease-free survival 0.641402 pathologic examination 0.580848 Kaplan-Meier estimates 0.57231	CLICK HERE
1562	National Cancer Institute	Html	en	Hypopharyngeal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of hypopharyngeal cancer.	cancer treatment 0.321266 high-dose radiation therapy 0.323579 centimeters 0.269921 cancer spreads 0.270417 malignant tumor cells 0.281954 body 0.305644 chemotherapy 0.290118 PDQ cancer information 0.346817 stage III hypopharyngeal 0.274417 clinical trial search 0.347149 clinical trials 0.698171 hypopharynx 0.280224 cancer information summary 0.319294 metastatic hypopharyngeal cancer 0.310093 clinical trial 0.551798 Recurrent hypopharyngeal cancer 0.306668 patients 0.317052 stage IV hypopharyngeal 0.274937 nearby soft tissue 0.271159 treatment clinical trial 0.275593 NCI PDQ cancer 0.283768 radiation therapy 0.705932 Treatment Editorial Board 0.281401 General information 0.289657 hypopharyngeal cancer 0.722179	general cancer information 0.275426 treatment 0.442202 new cancer treatments 0.272872 NCI-supported cancer 0.296123 cancer cells 0.361641 Cancer Information Service 0.276024 patient 0.26688 lymph nodes 0.350794 treatment clinical trials 0.300384 National Cancer Institute 0.364736 swollen lymph nodes 0.277694 new treatment 0.302418 External radiation therapy 0.314938 neck 0.309398 cancer research process 0.269057 cancer clinical trials 0.358746 stage 0.310003 neck cancer 0.286172 lymph node 0.322344 cancer information summaries 0.27414 comprehensive cancer information 0.274558 cancer 0.901171 standard treatment 0.274055 Hypopharyngeal Cancer Treatment 0.314822	CLICK HERE
1664	National Cancer Institute	Html	en	Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood atypical teratoid/rhabdoid tumors	cancer treatment 0.542006 metastatic brain tumors 0.391418 ongoing clinical trials 0.389415 PDQ cancer information 0.511527 tumor suppressor genes 0.452709 clinical trial search 0.399694 brain tumors 0.444671 CNS atypical teratoid/rhabdoid 0.388691 clinical trials 0.847224 Pediatric Treatment Editorial 0.416481 Teratoid/Rhabdoid Tumor Treatment 0.445097 cancer information summary 0.463674 clinical trial 0.521041 cancer cells 0.510172 stem cell transplant 0.396934 patients 0.411179 primary brain tumors 0.3918 treatment clinical trial 0.409064 NCI PDQ cancer 0.42324 radiation therapy 0.555658 Treatment Editorial Board 0.420841 Cord Tumors Treatment 0.414346 late effects 0.393798 treatment 0.689522 new cancer treatments 0.395428	PDQ treatment summary 0.447943 childhood brain 0.385451 Cancer Information Service 0.399251 specific cancer cells 0.397642 PDQ Pediatric Treatment 0.40786 treatment clinical trials 0.444124 National Cancer Institute 0.458723 spinal cord 0.616147 tumor cells 0.437516 effects cancer treatment 0.421518 new treatment 0.427513 childhood cancer information 0.400212 External radiation therapy 0.395094 brain tumor 0.405279 brain 0.467984 atypical teratoid/rhabdoid tumor 0.982554 PDQ summary 0.439127 cancer clinical trials 0.434177 cancer information summaries 0.39809 comprehensive cancer information 0.397631 cancer 0.740574 appropriate cancer treatment 0.419383 standard treatment 0.391688 fast-growing tumor 0.388774	CLICK HERE
1763	National Cancer Institute	Html	en	Anal Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing anal cancer and about research aimed at the prevention of this disease.	HPV status 0.37901 high-grade AIN 0.400535 HIV-positive men 0.374588 persistent HPV-6 0.369098 receptive anal intercourse 0.461565 Squamous cell cancer 0.399212 vulvar cancer survivors 0.380555 anal cancer SIR 0.523735 situ cervical cancer 0.423387 vaccine efficacy 0.403995 invasive vulvar cancer 0.380408 anal cancer risk 0.726451 anal exposure 0.434477 control-arm participants 0.42062 invasive cervical cancer 0.389499 anal cancers 0.477855 anal cancer diagnosis 0.502826 aforementioned multicountry cohort 0.36576 anal specimen 0.431502 anal cancer development 0.479231 HIV-positive MSM 0.39967 HIV-positive individuals 0.372051 baseline HPV status 0.371352 Anal HPV infection 0.502008	cell anal cancer 0.613468 per-protocol analysis 0.375594 cervical cancer survivors 0.388113 invasive cervical cancer. 0.365873 CI 0.564521 anal intraepithelial neoplasia 0.498397 oncogenic HPV strains 0.395201 anal infection 0.44494 anal cancer 0.940209 incidence rate 0.454386 cervical cancer 0.429644 sexual practices 0.401313 intent-to-treat analysis 0.37619 anal specimens 0.430195 HPV vaccine regimen 0.379059 invasive vaginal cancer 0.37973 squamous cell anal 0.539127 high-grade squamous cell 0.379806 cervical cancer prevention 0.379871 standardized incidence ratio 0.365263 unprotected anal 0.440711 HIV infection 0.421202 HIV-positive women 0.373444	CLICK HERE
1883	National Cancer Institute	Html	es	Tratamiento de los tumores extracraneales de células germinativas en la niñez (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de los tumores extracraneales de células germinativas en la niñez.	cell tumor protocols 0.408279 germinativas malignas localización 0.405353 células germinativas seminomatosos.Seminoma 0.410393 cell tumor combined 0.407867 germ cell tumours 0.412186 Perlman EJ 0.405253 Calaminus G 0.412513 Cell Cancer Collaborative 0.406794 cell tumors from 0.406747 Göbel U 0.406021 Cancer Group 0.42074 cell tumor studies 0.407558 pediatric oncology 0.41388 células germinativas mixtos 0.417539 International Germ Cell 0.417008 Children's Oncology Group 0.409014 mediastinal germ 0.406328 cell tumor study 0.408368 <2 cm 0.405406 Metástasis peritoneales macroscópicas 0.405941 germ cell neoplasms 0.406391 Children's Cancer 0.42175 cell tumors show 0.406094 pediatric germ 0.426106 adultos jóvenes 0.40725	estadio iv 0.405826 ganglios linfáticos ≥2 0.411723 Germ Cell Consensus 0.412507 Cushing B 0.405386 teratomas benignos 0.407141 Genes Chromosomes Cancer 0.438953 with germ 0.406335 malignant germ cell 0.462527 PDQ Tratamiento 0.405882 childhood germ 0.409831 cell tumors based 0.405903 Clin Oncol 0.444548 saco vitelino 0.435575 linfáticos ≥2 cm 0.408554 Schneider DT 0.409517 Children's Cancer Group 0.419331 Cell Consensus Classification 0.409901 germ cell tumors 0.974328 Kingdom Children Cancer 0.408316 germ cell cancer 0.410294 Children's Cancer Study 0.409136 pediatric oncology group 0.410202 oncology group 0.420408 Cancer Study Group 0.411644	CLICK HERE
2000	National Cancer Institute	Html	es	Tratamiento de la histiocitosis de células de Langerhans (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la histiocitosis de células de Langerhans.	cuánto aire 0.415134 siguientes procedimientos 0.528715 células madre 0.858073 adultos jóvenes 0.464664 efectos secundarios meses 0.439126 siguientes aspectos 0.434701 faja ajustadora 0.428231 HCL infantil multisistémica 0.546722 cuántos sistemas 0.518567 genes ras 0.453948 pequeña cantidad 0.423844 células normales.ampliar exploración 0.532323 vía oral 0.42013 rayos x 0.425227 gen braf 0.666188 largo plazo 0.44968 cuántas células 0.518957 niño ayuda 0.426203 efectos tardíos 0.516221 escáner.ampliar exploración 0.429231 tarde.ampliar ecografía 0.427113	vías respiratorias 0.424871 causa problemas 0.424997 lesiones óseas 0.423193 National Cancer Institute 0.417904 IRMN).Ampliar Imágenes 0.421648 siguientes riesgos 0.415861 radiación uvb 0.414555 Instituto Nacional 0.431398 PDQ Tratamiento 0.451873 antecedentes familiares 0.589915 llamada genes ras 0.432872 explorador tep 0.430081 terapia fotodinámica causa 0.453098 sistema nervioso central 0.604707 Physician Data Query 0.464236 mayores probabilidades 0.416225 HCL multisistémica 0.966875 terapia fotodinámica llamada 0.451949 radiación ultravioleta 0.561342 siguientes pruebas 0.489919	CLICK HERE
15487	National Cancer Institute	Html	en	Seeking Cancer Clues in Blood, Researchers Explore Exosomes	A feature-length Research Update article about exploring ways to use vesicles known as exosomes to develop new clinical tests and tools for patients with cancer.	Dr. Alvarez 0.382039 exciting preliminary study 0.288255 Hector Alvarez 0.230222 organ-specific metastases 0.263438 research 0.34419 unneeded proteins 0.218149 cancer-associated genetic alterations 0.292328 Ph.D. 0.232319 reliable diagnostic biomarkers 0.286894 pancreatic tumors 0.316162 tumor-derived exosomes 0.435098 liver metastases 0.261607 distant sites 0.270026 David Lyden 0.230954 potential source 0.27056 potentially debilitating surgery 0.288289 researchers 0.33374 exosomal DNA 0.235697 generally reliable source 0.276449 ultimate goal 0.288377 liquid biopsy tests 0.276523 Dr. Lyden 0.452577 cell-free DNA 0.302958 Weill Cornell Medicine 0.277332 coauthor Bruno Costa-Silva 0.277568	different cells 0.270221 exosome-derived DNA 0.320829 potential clinical application 0.294125 primary cancer 0.228119 lung metastases 0.261657 cancer cells 0.736815 accompanying editorial 0.30439 Trinity College Dublin 0.290697 primary tumor cells 0.384123 release exosomes 0.30546 originating cells 0.294925 high-quality DNA 0.233017 metastases 0.284855 distant locations 0.221908 diagnostic blood test 0.298912 exosomes 0.914671 Cancer Research 0.263148 pancreatic cancer cells 0.436342 specific cells 0.275707 MD Anderson Cancer 0.353274 clinical tools 0.317657 breast cancer 0.228037 genetic changes 0.218672 tumor DNA 0.385381	CLICK HERE
15640	National Cancer Institute	Html	null	Research & Development (R&D) Contracts	null			CLICK HERE
16683	National Cancer Institute	Html	es	714-X (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso del 714-X como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Alternative Medicine Confronts 0.349 Task Force 0.681834 Rock Forest 0.4465 Cancer Research Initiative 0.920081 Radiosensitizing effect 0.323708 but not 0.32369 Goel HC 0.323157 Alternative Therapeutic 0.727518 Bacteria Cause Cancer 0.362108 Unconventional therapies 0.71198 Breast Cancer Research 0.913503 saccharin-LiCl conditioned stimulus 0.34146 Roa AR 0.322774 transplantable mammary 0.323668 Instituto Nacional 0.49296 Pharmacol Biochem Behav 0.342417 Pavlovian conditioning 0.324132 PDQ 714-X 0.384196 posibles efectos 0.32412 Estados Unidos 0.547224 Canadian Breast Cancer 0.923206 for bacteria as 0.342644 vía nasal 0.324957 Purohit A 0.322533 New York University 0.333776	alcanfor mejora 0.352671 Conditioned enhancement 0.324112 linfoma caninos 0.323743 CERBE Distribution 0.468077 Solvason HB 0.367895 Hiramoto RN 0.325133 new approach 0.322794 empresa distribuidora 0.324674 National Cancer Institute 0.431242 Hiramoto NS 0.502986 vitamina b12 0.324597 New York 0.3535 accessed april 0.467486 Neurosci Res 0.325453 numerosos oligoelementos 0.325391 Physician Data Query 0.337084 Hess DJ 0.368799 libre uso 0.325033 linfosarcoma murinos 0.323938 Ghanta VK 0.432317 cartílago bovino 0.325426 killer cell activity 0.342736 response to yc8 0.339588 Soong SJ 0.323559	CLICK HERE